title: [Spasticity and multiple sclerosis].
abstract: Spasticity is a common symptom in MS patients. It is easy to recognize and evaluate spasticity at rest. The efficacy of numerous treatments has been well documented. Nevertheless, it is difficult, particularly in MS patients, to assess the functional disability due to spasticity and the functional benefit due to treatment. This is why it is appears more appropriate to use therapeutic tests with transitory effects such as anesthetic blocks in case of focal spasticity or intrathetical baclofen in case of diffuse spasticity. It is also possible to use reversible treatments such as botulinum toxin injections before proposing section of a peripheral nerve.
authors.affiliation: Service de rééducation neurologique, Hôpital R. Poincaré, 92380 Garches.
authors.forename: B
authors.initials: B
authors.lastname: Bussel
authors.forename: O R
authors.initials: OR
authors.lastname: Neris
authors.forename: L
authors.initials: L
authors.lastname: Mailhan
mesh_terms: D004185:Disability Evaluation; D006801:Humans; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000628:therapy; D009128:Muscle Spasticity / Q000175:diagnosis* / Q000628:therapy; D009460:Neurologic Examination; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000009:adverse effects; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D009465:Neuromuscular Agents
vernacular_title: Spasticité et SEP.